Excited to share that we recently received an R21 (R21AI176186) from the NIH to explore novel concepts in mRNA vaccines for Toxoplasma gondii. This is in collaboration with Lawrence Livermore National Laboratories (LLNL) nanoparticle vaccine group headed by Dr. Nick Fischer and Dr. Amy Rasley.